Oligonucleotides

huntingtin ; Mus musculus







17 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35143966 Cerebrospinal fluid mutant huntingtin is a biomarker for huntingtin lowering in the striatum of Huntington disease mice. 2022 May 2
2 34918046 Therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs. 2021 Dec 16 4
3 31648394 Mesenchymal stem cells alleviate AQP-4-dependent glymphatic dysfunction and improve brain distribution of antisense oligonucleotides in BACHD mice. 2020 Feb 1
4 30282695 Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease. 2018 Oct 3 1
5 28182673 The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain. 2017 2
6 28453524 Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease. 2017 2
7 27033979 Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin. 2016 Jun 14 1
8 27721240 Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. 2016 Nov 1 2
9 24347167 Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin. 2014 Feb 7 1
10 24380395 Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification. 2014 Feb 4
11 25035419 Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity. 2014 Dec 1 2
12 25101598 In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides. 2014 Dec 1
13 25155142 Targets for future clinical trials in Huntington's disease: what's in the pipeline? 2014 Sep 15 1
14 25063516 Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease. 2013 1
15 22726826 "Huntingtin holiday": progress toward an antisense therapy for Huntington's disease. 2012 Jun 21 1
16 22726834 Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. 2012 Jun 21 2
17 12165556 Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. 2002 Aug 15 1